KOSDAQ - Delayed Quote KRW

Medy-Tox Inc. (086900.KQ)

162,700.00
-200.00
(-0.12%)
At close: 3:30:26 PM GMT+9
Currency in KRW All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
228,621,969
228,621,969
221,120,683
195,096,220.13
184,869,547.95
Cost of Revenue
89,593,238
89,593,238
87,249,734
68,691,039.13
79,016,752.88
Gross Profit
139,028,731
139,028,731
133,870,949
126,405,181
105,852,795.07
Operating Expense
118,680,009
118,680,009
116,548,620
79,739,992
71,361,278
Operating Income
20,348,722
20,348,722
17,322,329
46,665,189
34,491,517.07
Net Non Operating Interest Income Expense
-801,739
-801,739
-1,436,550
-1,702,760.02
-3,823,462.30
Pretax Income
17,499,170
17,499,170
15,853,002
49,526,136.52
128,265,330.91
Tax Provision
1,425,399
1,425,399
6,163,181
12,930,300.92
35,002,681.87
Net Income Common Stockholders
16,954,995
16,954,995
9,755,099
37,009,995.37
94,153,921.07
Basic EPS
2.38k
--
1.31k
5.77k
15.32k
Diluted EPS
2.38k
--
1.31k
5.76k
15.24k
Basic Average Shares
7,132.94
--
7,440.96
6,418.66
6,146.96
Diluted Average Shares
7,132.94
--
7,440.96
6,420.89
6,176.92
Total Operating Income as Reported
20,348,723
20,348,723
17,322,329
46,664,445.39
34,491,517.17
Rent Expense Supplemental
442,836
442,836
527,841
479,450
285,230
Total Expenses
208,273,247
208,273,247
203,798,354
148,431,031.13
150,378,030.88
Net Income from Continuing & Discontinued Operation
16,954,995
16,954,995
9,755,099
37,009,995.37
94,153,921.07
Normalized Income
23,764,310.64
23,764,310.64
10,896,380.44
41,212,461.98
102,047,448.75
Interest Income
925,154
925,154
896,430
610,755
957,220
Interest Expense
1,726,893
1,726,893
2,332,980
2,313,515
4,780,682
Net Interest Income
-801,739
-801,739
-1,436,550
-1,702,760.02
-3,823,462.30
EBIT
19,226,063
19,226,063
18,185,982
51,839,651.52
133,046,012.91
EBITDA
39,184,832
39,184,832
33,561,701
66,940,846.52
151,301,657.91
Reconciled Cost of Revenue
89,593,238
89,593,238
87,249,734
68,691,039.13
79,016,752.88
Reconciled Depreciation
19,958,769
19,958,769
15,375,719
15,101,195
18,255,645
Net Income from Continuing Operation Net Minority Interest
16,954,995
16,954,995
9,755,099
37,009,995.37
94,153,921.07
Total Unusual Items Excluding Goodwill
-7,413,156
-7,413,156
-1,867,190
-5,687,312
-10,856,071
Total Unusual Items
-7,413,156
-7,413,156
-1,867,190
-5,687,312
-10,856,071
Normalized EBITDA
46,597,988
46,597,988
35,428,891
72,628,158.52
162,157,728.91
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-603,840.36
-603,840.36
-725,908.56
-1,484,845.39
-2,962,543.32
12/31/2021 - 1/16/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade